药物相关损害应被视为老年综合征
本文提出药物相关损害(MRH)在老年人中因多病共存和多药用药而增加,英格兰NHS因此承担约4亿英镑成本;现有聚焦多药用药和药物适宜性的策略效果不一且常令人失望。作者建议将MRH本身视为一种老年综合征,采用涵盖生理变化与心理社会因素的更广泛概念模型,并在健康与社会照护边界内协调、个体化地主动监测和审查老年人用药。
要点
- MRH在老年人中因多病共存和多药用药而增加,英格兰NHS成本约4亿英镑。
- 现有聚焦多药用药和药物适宜性的策略对生活质量、临床和经济结局影响不一且常令人失望。
- 建议将MRH视为老年综合征,采用涵盖生理变化与心理社会因素的广泛概念模型。
核心结论
- 应更重视药物相关损害,并将其本身视为一种老年综合征,以协调且个体化的方式跨健康与社会照护边界加以应对。
研究设计与样本
- 本文为论述性文章,基于WHO全球患者安全挑战「无伤害用药」背景提出概念模型与主张,未报告系统检索或样本量。
主要发现
- 寿命延长合并多病共存和多药用药导致MRH发生率增加,尤其在老年人中,英格兰NHS成本约4亿英镑。
- 现有策略多聚焦多药用药和药物适宜性,但对生活质量、临床和经济结局的影响不一且常令人失望。
- 新出现的证据提示需采用更广泛方法,将公认的生理变化及较少考虑的心理社会问题纳入MRH概念模型。
关键数值与推荐
- 作者推荐将MRH视为老年综合征,并更主动地监测和审查老年人用药以响应其变化的需求。
- 管理MRH应与老年综合征管理相平行,采用跨健康与社会照护边界的协调且个体化方法。
临床怎么用
- 临床应更主动监测和审查老年人用药,并随其需求变化调整。
- 处理MRH时除多药用药和药物适宜性外,还需考虑生理变化与心理社会因素。
- 应在健康与社会照护边界内协调且个体化地应对MRH。
局限性
- 本文为论述性文章,未报告系统检索、样本量或定量结局数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The WHO Global Patient Safety Challenge: Medication Without Harm recognises medication-related harm (MRH) as a global public health issue. Increased life-expectancy coupled with multimorbidity and polypharmacy leads to an increased incidence of MRH, especially in older adults: at a cost of approximately £400 million to the National Health Service (NHS) in England. Harm from medicines has long been recognised by geriatricians, and strategies have been developed to mitigate harm. In general, these have focused on the challenges of polypharmacy and appropriateness of medicines, but impact on the quality of life, clinical and economic outcomes has been variable and often disappointing. The problem of MRH in older adults will continue to grow unless a new approach is adopted. Emerging evidence suggests that we need to take a broader approach as described in our conceptual model, where well-recognised physiological changes are incorporated, as well as other rarely considered psychosocial issues that influences MRH. Parallels may be drawn between this approach and the management of geriatric syndromes. We propose there must be a greater emphasis on MRH, and it, of itself, should be considered as a geriatric syndrome, to bring the spotlight onto the problem and to send a clear signal from geriatric experts that this is an important issue that needs to be addressed using a co-ordinated and tailored approach across health and social care boundaries. This requires a more proactive approach to monitor and review the medicines of older adults in response to their changing need.
引用
- Stevenson JM, Davies JG, Martin FC, et al. Medication-related harm: a geriatric syndrome. Age Ageing. 2019. PMID: 31665207. doi:10.1093/ageing/afz121
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。